Terveystalo Oyj
TTALF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $322 | $347 | $354 | $296 |
| % Growth | -7.3% | -2% | 19.6% | – |
| Cost of Goods Sold | $128 | $138 | $144 | $122 |
| Gross Profit | $193 | $209 | $210 | $174 |
| % Margin | 60.1% | 60.3% | 59.2% | 58.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3 | $4 | $3 | $3 |
| Sales & Mktg Exp. | $3 | $4 | $3 | $3 |
| Other Operating Expenses | $157 | $159 | $176 | $146 |
| Operating Expenses | $160 | $163 | $179 | $149 |
| Operating Income | $33 | $46 | $31 | $25 |
| % Margin | 10.4% | 13.4% | 8.7% | 8.5% |
| Other Income/Exp. Net | -$6 | -$5 | -$7 | -$7 |
| Pre-Tax Income | $28 | $41 | $24 | $18 |
| Tax Expense | $6 | $8 | $5 | $4 |
| Net Income | $22 | $33 | $19 | $15 |
| % Margin | 6.9% | 9.6% | 5.4% | 5% |
| EPS | 0.18 | 0.26 | 0.15 | 0.12 |
| % Growth | -30.8% | 73.3% | 25% | – |
| EPS Diluted | 0.17 | 0.26 | 0.15 | 0.12 |
| Weighted Avg Shares Out | 127 | 127 | 127 | 127 |
| Weighted Avg Shares Out Dil | 131 | 127 | 127 | 127 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $1 | $1 |
| Interest Expense | $5 | $5 | $7 | $8 |
| Depreciation & Amortization | $24 | $24 | $29 | $26 |
| EBITDA | $57 | $70 | $60 | $51 |
| % Margin | 17.7% | 20.3% | 16.9% | 17.4% |